| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.32 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |